Role of HIF-1α-activated Epac1 on HSC-mediated neuroplasticity in stroke model

Neurobiology of Disease

Volumn 58, Issue , 2013, Pages 76-91

  Lin, Chen Huan ^a   Lee, Hsu Tung ^b,c   Lee, Shin Da ^d,e   Lee, Wei ^a   Cho, Chin Wen Chental ^a   Lin, Shinn Zong ^a,d   Wang, Hsiao Jung ^a   Okano, Hideyuki ^f   Su, Ching Yuan ^g   Yu, Yung Luen ^d   Hsu, Chung Y ^d   Shyu, Woei Cherng ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

Cerebral ischemia; Epac1; HUCB34; Hypoxia preconditioning (HP); Immunoselection of CD34

Indexed keywords

CD34 ANTIGEN; EXCHANGE PROTEIN ACTIVATED BY CAMP 1; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE; RAP1 PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEURAL STEM CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; UPREGULATION;

CD34-IMMUNOSORTED HUMAN UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELLS; CEREBRAL ISCHEMIA; EPAC1; EXCHANGE PROTEIN ACTIVATED BY CAMP; HUCB; HUCB(34); HUMAN UMBILICAL CORD BLOOD; HYPOXIA PRECONDITIONING (HP); IMMUNOSELECTION OF CD34;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD34; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; ESTRADIOL; GLUCOSE; GREEN FLUORESCENT PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STROMAL CELLS; MICE, TRANSGENIC; NERVE REGENERATION; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; TUBULIN MODULATORS; UP-REGULATION;

EID: 84879387756     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.05.006     Document Type: Article

References (66)

1. Aharoni R., et al. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis. J. Neurosci. 2005, 25:8217-8228.
2. Ahn G.O., Brown J.M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008, 13:193-205.
3. Amantea D., et al. Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion. Neuroscience 2008, 152:8-17.
4. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
5. Bai L., et al. Human mesenchymal stem cells signals regulate neural stem cell fate. Neurochem. Res. 2007, 32:353-362.
6. Bedogni B., et al. Notch1 is an effector of Akt and hypoxia in melanoma development. J. Clin. Invest. 2008, 118:3660-3670.
7. Borlongan C.V., et al. Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats. Neuroreport 1998, 9:2837-2842.
8. Bos J.L. Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 2006, 31:680-686.
9. Cafferty W.B., et al. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J. Neurosci. 2004, 24:4432-4443.
10. Cai Z., et al. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc. Res. 2008, 77:463-470.
11. Carmichael S.T., et al. Evolution of diaschisis in a focal stroke model. Stroke 2004, 35:758-763.
12. Carmona G., et al. Activation of Epac stimulates integrin-dependent homing of progenitor cells. Blood 2008, 111:2640-2646.
13. Chang C.F., et al. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 2003, 34:558-564.
14. Chen S.T., et al. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 1986, 17:738-743.
15. Chen J., et al. Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J. Neurol. Sci. 2002, 199:17-24.
16. Chen X., et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002, 22:275-279.
17. Daadi M.M., et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 2010, 41:516-523.
18. Dai Y., et al. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J. Mol. Cell. Cardiol. 2007, 42:1036-1044.
19. Del Bigio M.R., et al. Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells. Neuropathol. Appl. Neurobiol. 1999, 25:54-62.
20. Dunnett S.B., et al. A lateralised grip strength test to evaluate unilateral nigrostriatal lesions in rats. Neurosci. Lett. 1998, 246:1-4.
21. El Zein N., et al. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1. J. Leukoc. Biol. 2008, 83:972-981.
22. Enserink J.M., et al. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 2002, 4:901-906.
23. Ganea E., et al. Matrix metalloproteinases: useful and deleterious. Biochem. Soc. Trans. 2007, 35:689-691.
24. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
25. Goichberg P., et al. cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors. Blood 2006, 107:870-879.
26. Gray M.J., et al. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005, 24:3110-3120.
27. Hamacher K., et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 1986, 27:235-238.
28. Hayashidani S., et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1229-H1235.
29. Hess D.A., et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006, 107:2162-2169.
30. Holz G.G. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 2004, 53:5-13.
31. Kekarainen T., et al. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol. 2006, 7:30.
32. Kim J.Y., et al. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 2004, 199:113-124.
33. Kitamura Y., et al. Intracerebroventricular injection of microglia protects against focal brain ischemia. J. Pharmacol. Sci. 2004, 94:203-206.
34. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
35. Lee S.R., et al. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J. Neurosci. 2006, 26:3491-3495.
36. Lee S.H., et al. Arachidonic acid potentiates hypoxia-induced VEGF expression in mouse embryonic stem cells: involvement of Notch, Wnt, and HIF-1alpha. Am. J. Physiol. Cell Physiol. 2009, 297:C207-C216.
37. Liu F., Whitton J.L. Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J. Immunol. 2005, 174:5936-5940.
38. McPhee I., et al. Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease. Biochem. Soc. Trans. 2005, 33:1330-1332.
39. Morris D.C., et al. High resolution quantitation of microvascular plasma perfusion in non-ischemic and ischemic rat brain by laser-scanning confocal microscopy. Brain Res. Brain Res. Protoc. 1999, 4:185-191.
40. Munoz J.R., et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18171-18176.
41. Namkoong S., et al. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cell. Signal. 2009, 21:906-915.
42. Oh L.Y., et al. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J. Neurosci. 1999, 19:8464-8475.
43. Park S., et al. Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. Neurosci. Lett. 2003, 353:91-94.
44. Pasino M., et al. Flow cytometric and functional characterization of AC133+ cells from human umbilical cord blood. Br. J. Haematol. 2000, 108:793-800.
45. Perez S.E., et al. Matrix metalloproteinases 2 and 9 are dispensable for pancreatic islet formation and function in vivo. Diabetes 2005, 54:694-701.
46. Pescador N., et al. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 2005, 390:189-197.
47. Rivera F.J., et al. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 2006, 24:2209-2219.
48. Sawamoto K., et al. Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J. Neurosci. 2001, 21:3895-3903.
49. Schioppa T., et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 2003, 198:1391-1402.
50. Shyu W.C., et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110:1847-1854.
51. Shyu W.C., et al. Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J. Clin. Invest. 2008, 118:133-148.
52. Shyu W.C., et al. Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. J. Clin. Invest. 2008, 118:2482-2495.
53. Signorelli S., et al. Differential effects of hypoxic stress in alveolar epithelial cells and microvascular endothelial cells. Cell. Physiol. Biochem. 2010, 25:135-144.
54. Staun-Ram E., et al. Ets-2 and p53 mediate cAMP-induced MMP-2 expression, activity and trophoblast invasion. Reprod. Biol. Endocrinol. 2009, 7:135.
55. Takahashi S., et al. Cyclic adenosine 3',5'-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts. J. Biol. Chem. 1991, 266:19894-19899.
56. Terada N., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416:542-545.
57. Ulucan C., et al. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1662-H1672.
58. Vaudry D., et al. Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002, 296:1648-1649.
59. Wachs F.P., et al. High efficacy of clonal growth and expansion of adult neural stem cells. Lab. Invest. 2003, 83:949-962.
60. Wei L., et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol. Dis. 2005, 19:183-193.
61. Wislet-Gendebien S., et al. Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4. BMC Neurosci. 2004, 5:33.
62. Yokoyama U., et al. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1547-H1555.
63. Yong V.W., et al. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998, 21:75-80.
64. Zhang Y., et al. CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism. J. Neurosci. 2007, 27:4499-4506.
65. Zhao Z.M., et al. Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant. 2004, 13:113-122.
66. Zuo J., et al. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 1998, 18:5203-5211.